Thomas Lee Jang MD MPH, FACS

Professor and Chief of Urologic Oncology at the Rutgers Cancer Institute; Program Director, Rutgers RWJ Medical School Urology Residency Training Program

Join to View Full Profile

195 Little Albany StNew Brunswick, NJ 08903
Phone+1 732-235-2043
Fax+1 732-235-6596

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2006 - 2009
McGaw Medical Center of Northwestern UniversityResidency, Urology, 2002 - 2006
McGaw Medical Center of Northwestern UniversityResidency, Surgery, 2000 - 2002
Northwestern University Graduate SchoolMPH, Epidemiology & Biostatistics, 2000 - 2001
Northwestern University The Feinberg School of MedicineClass of 2000

Certifications & Licensure

ND State Medical License 2009 - 2026
NJ State Medical License 2009 - 2025
NY State Medical License 2006 - 2025
IL State Medical License 2000 - 2008
American Board of Urology Urology

Awards, Honors, & Recognition

Recognition as Testicular Cancer Expert Testicular Cancer Resource Center/Testicular Cancer Society
Residents and Fellows Committee Teaching Award Nominee American Urological Association, 2021
New Jersey Monthly Top Doctor in Urology/Urologic Oncology NJ Monthly, 2020
Faculty Teaching Award Urology Residency Program at Rutgers RWJ Medical School, 2011, 2016-2020
Arnold P. Gold Foundation Award on Humanism in Health Care Delivery
Northwestern University Alumni Association and GME Excellence in Medical Student Teaching Award Northwestern University Medical School
Leander Riba Award for Skill and Compassion in Patient Care Northwestern University, Department of Urology
American Urological Association Research Scholar American Foundation for Urologic Disease and American Urological Association
First Place, Chicago Urological Society Charles Huggins Research Contest Chicago Urological Society
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma Start of enrollment: 2015 Aug 28
Active, not recruiting
Not Applicable
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
ACTIVE_NOT_RECRUITING
PHASE3
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer Start of enrollment: 2018 Mar 20
ACTIVE_NOT_RECRUITING
PHASE2
A Study of MiRNA 371 in Patients with Germ Cell Tumors Start of enrollment: 2020 Jul 28
ACTIVE_NOT_RECRUITING
Join now to see all

Publications & Presentations

PubMed

Rethinking the definition of stage III disease in adrenocortical carcinoma: Assessing the impact of clinical lymph node positive disease.
Benjamin J Lichtbroun, Helen Gao, Kevin Chua, John Pfail, Rachel Passarelli
Urologic Oncology. 2025-04-01
1 citations
National Surgical Quality Improvement Program audit of contemporary perioperative care for radical cystectomy.
John Pfail, Jasmin Capellan, Rachel Passarelli, Alain Kaldany, Kevin Chua
BJU International. 2025-01-01
1 citations
Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell Tumors.
Jennifer Sykes, Alain Kaldany, Thomas L Jang
Journal of Clinical Medicine. 2024-12-06

Journal Articles

Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer Database
Parth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology

Press Mentions

Check Yourself: Why Being Proactive About Testicular Cancer MattersApril 1st, 2025
April Is Testicular Cancer Awareness MonthApril 26th, 2023
Rutgers Cancer Institute of New Jersey Experts Available for Comment During Men’s Health MonthJune 7th, 2021
Join now to see all